Due to its demonstrated cellular toxicity and the ability to trigger the elicitation of the neuronal ISR, C99 is fully qualified for such a role, which is consistent with the observation of substantial accumulation of C99 in AD-affected neurons but not in the disease-resistant regions of the human brain. Here, APP is linked to Alzheimer disease.